Egypt's Eva Pharma begins producing COVID-19 drug Remdesivir - (Financial Post via NewsPoints Desk)

  • Egypt’s Eva Pharma has begun producing remdesivir and favipiravir to treat patients with COVID-19, as reported in the Financial Post.

  • Earlier this month, Eva Pharma received a licence from Gilead Sciences to produce remdesivir in Egypt and distribute it to 127 countries.

  • The drugmaker will initially make 500,000 doses a month to be sold at a price less than 2000 Egyptian pounds each, said general manager Amgad Talaat, adding that they’ve already started delivering the medicine to hospitals.

  • Talaat said that Eva Pharma has also started producing 1 million favipiravir tablets a month, which will be on the market within two to three weeks.

  • The company hopes to sell any excess doses to other Middle Eastern and African countries, said Talaat.

To read more NewsPoints articles, click here.